MarketCapTrends
VNRX
VolitionRx Limited (VNRX)
NYSE · Healthcare

VolitionRx Limited Shareholder Equity 2011–2025

VolitionRx Limited annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • VolitionRx Limited shareholder equity for the quarter ending December 31, 2025 were -34.2M, a 37.49% increase year-over-year.
  • VolitionRx Limited shareholder equity for 2025 were -34.2M, a 37.49% increase from 2024.
  • VolitionRx Limited shareholder equity for 2024 were -24.9M, a 219.24% increase from 2023.
  • VolitionRx Limited shareholder equity for 2023 were -7.8M, a 203.00% increase from 2022.
  • VolitionRx Limited shareholder equity for 2022 were -2.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
VolitionRx Limited Annual Shareholder Equity (Millions of US $)
2025$-34
2024$-25
2023$-8
2022$-3
2021$18
2020$16
2019$14
2014$0
2012$1
2011$1
VolitionRx Limited Quarterly Shareholder Equity (Millions of US $)
2025-12-31$-34
2024-12-31$-25
2023-12-31$-8
2022-12-31$-3
2021-12-31$18
2020-12-31$16
2019-12-31$14
2014-12-31$0
2012-12-31$1
2011-12-31$1

VolitionRx Limited Shareholder Equity — FAQ

VolitionRx Limited (VNRX) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VNRX's shareholder equity history?

The chart and table above show VolitionRx Limited's shareholder equity by year and by quarter, including the growth rate.